FADS1 and acute myeloid leukemia: Since FADS1 was also elevated in AMLs bearing FLT3ITD, we also assessed how shRNA-mediated inhibition impacted the expansion of a mouse AML cell line expressing FLT3ITD and a Dnmt3aR878H mutation (homologous to the DNMT3AR882H mutant found in human AML).